PT- 141 (10 vials)
PT-141, also known as Bremelanotide, is a melanocortin receptor peptide extensively studied for receptor signaling and neurobiology research. Its unique mechanism continues to attract significant scientific interest.
PT-141, Bremelanotide, PT141 Peptide, Research Compound
Research-grade PT-141 peptide for laboratory research involving melanocortin receptors and neurobiology.
Disclaimer: Our peptides are research-grade products for laboratory use only. They are not approved for human consumption or medical use. Always follow proper laboratory safety protocols.
PT-141 (Bremelanotide) Research Peptide
PT-141 (Bremelanotide) is a synthetic research peptide derived from α-melanocyte-stimulating hormone (α-MSH) analogs and classified as a melanocortin receptor agonist. It is commonly used in laboratory research to investigate melanocortin receptor signaling, neuroendocrine function, and central nervous system (CNS) pathways. Its receptor selectivity makes it a valuable tool for studying peptide-mediated signaling in controlled experimental settings.
Neuroendocrine Research
In laboratory studies, PT-141 is investigated for its interaction with melanocortin receptors and the downstream signaling pathways involved in neuroendocrine regulation. Researchers use this peptide to examine receptor activation, endocrine signaling, and the complex interactions between neural and hormonal systems.
Central Nervous System Research
PT-141 is frequently incorporated into studies exploring central nervous system signaling and neuronal communication. Research models may evaluate receptor-mediated neural activity, neurotransmitter pathways, and hormone-related signaling networks to better understand the role of melanocortin receptors in neurological function.
Melanocortin Receptor Activity
A defining characteristic of PT-141 is its selective activation of melanocortin receptors. This receptor profile enables researchers to investigate how melanocortin signaling influences neuroendocrine pathways, neural communication, and integrated physiological responses within experimental models.
Lyophilized Research Format
This product is supplied as a sterile 10 mg lyophilized (freeze-dried) powder to promote stability during storage and handling. The lyophilized formulation supports accurate reconstitution and consistent preparation under appropriate laboratory conditions, making it suitable for dose-response studies and extended research protocols.
Storage Recommendations
For optimal stability, store the unreconstituted peptide according to laboratory best practices. After reconstitution with an appropriate laboratory-grade solution, refrigerated storage between 2°C and 8°C is generally recommended to help maintain peptide integrity throughout laboratory research.
Research Applications
- Synthetic melanocortin receptor agonist for laboratory research
- Studied in neuroendocrine and central nervous system research models
- Investigated for melanocortin receptor signaling pathways
- Used to examine neural communication and hormone-related signaling
- Lyophilized powder formulation for stability and consistent laboratory preparation
- Intended exclusively for qualified laboratory research use
PT-141 continues to be an important research peptide for scientists investigating melanocortin receptor biology, neuroendocrine regulation, and central nervous system signaling. Its selective receptor activity makes it a valuable addition to laboratory research programs focused on understanding receptor-mediated physiological processes.
Disclaimer: PT-141 (Bremelanotide) is supplied exclusively for laboratory research purposes. It is not intended for human or veterinary use, medical treatment, diagnosis, or therapeutic application. All handling and use should comply with applicable laboratory regulations and institutional research standards.